Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-21-000293
Filing Date
2021-02-09
Accepted
2021-02-09 11:59:14
Documents
49
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 SANGUI BIOTECH INTERNATIONAL INC - FORM 10-Q SEC FILING sgbi-20201231.htm   iXBRL 10-Q 688239
2 CERTIFICATION sgbi_ex31z01.htm EX-31.01 7722
3 CERTIFICATION sgbi_ex31z02.htm EX-31.02 8226
4 CERTIFICATION sgbi_ex32z01.htm EX-32.01 4333
  Complete submission text file 0001096906-21-000293.txt   2596428

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgbi-20201231_cal.xml EX-101.CAL 25112
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgbi-20201231_def.xml EX-101.DEF 54145
7 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgbi-20201231_lab.xml EX-101.LAB 136031
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgbi-20201231_pre.xml EX-101.PRE 123387
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgbi-20201231.xsd EX-101.SCH 52410
10 EXTRACTED XBRL INSTANCE DOCUMENT sgbi-20201231_htm.xml XML 350134
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

EIN.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 21604806
SIC: 2834 Pharmaceutical Preparations